Curcumenol does not serve as a mechanism-dependent inhibitor, Based on exploration into time- and nicotinamide adenine dinucleotide phosphate-dependent inhibition. However, supplied the limited pharmacokinetic data available, the promising clinical results of curcumenol on clients are not likely to have been adequately evaluated. Accordingly, more investigation need to be carried out https://jacku742kos5.blogozz.com/profile